Laura Biddick

423 total citations
24 papers, 338 citations indexed

About

Laura Biddick is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Laura Biddick has authored 24 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Laura Biddick's work include Cancer, Hypoxia, and Metabolism (5 papers), Inflammatory mediators and NSAID effects (5 papers) and Epigenetics and DNA Methylation (4 papers). Laura Biddick is often cited by papers focused on Cancer, Hypoxia, and Metabolism (5 papers), Inflammatory mediators and NSAID effects (5 papers) and Epigenetics and DNA Methylation (4 papers). Laura Biddick collaborates with scholars based in United States. Laura Biddick's co-authors include Chinthalapally V. Rao, Stan Lightfoot, Altaf Mohammed, Vernon E. Steele, Venkateshwar Madka, Misty Brewer, Jagan M.R. Patlolla, Naveena B. Janakiram, Naveena B. Janakiram and Yuting Zhang and has published in prestigious journals such as Cancer Research, Scientific Reports and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Laura Biddick

24 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Biddick United States 12 189 91 70 48 45 24 338
Misty Brewer United States 12 261 1.4× 195 2.1× 110 1.6× 40 0.8× 29 0.6× 21 435
Donatella D’Eliseo Italy 9 200 1.1× 100 1.1× 104 1.5× 24 0.5× 83 1.8× 9 443
Liang You United States 14 241 1.3× 98 1.1× 82 1.2× 48 1.0× 33 0.7× 22 419
Jelena Zarić Switzerland 8 162 0.9× 64 0.7× 45 0.6× 90 1.9× 33 0.7× 15 377
Daniel LaSala United States 11 202 1.1× 50 0.5× 35 0.5× 30 0.6× 38 0.8× 17 454
Fiona McPhillips United Kingdom 6 274 1.4× 62 0.7× 43 0.6× 38 0.8× 58 1.3× 7 521
Ann‐Marie Simeone United States 11 208 1.1× 95 1.0× 96 1.4× 66 1.4× 44 1.0× 13 399
Xinxin Xiong China 10 184 1.0× 84 0.9× 94 1.3× 43 0.9× 56 1.2× 17 417
Bin Wen China 11 240 1.3× 61 0.7× 94 1.3× 83 1.7× 36 0.8× 21 407
Youxiang Ding China 12 248 1.3× 83 0.9× 82 1.2× 55 1.1× 64 1.4× 16 399

Countries citing papers authored by Laura Biddick

Since Specialization
Citations

This map shows the geographic impact of Laura Biddick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Biddick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Biddick more than expected).

Fields of papers citing papers by Laura Biddick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Biddick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Biddick. The network helps show where Laura Biddick may publish in the future.

Co-authorship network of co-authors of Laura Biddick

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Biddick. A scholar is included among the top collaborators of Laura Biddick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Biddick. Laura Biddick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mohammed, Altaf, Naveena B. Janakiram, Venkateshwar Madka, et al.. (2019). Intermittent Dosing Regimens of Aspirin and Naproxen Inhibit Azoxymethane-Induced Colon Adenoma Progression to Adenocarcinoma and Invasive Carcinoma. Cancer Prevention Research. 12(11). 751–762. 12 indexed citations
2.
Mohammed, Altaf, Naveena B. Janakiram, Venkateshwar Madka, et al.. (2018). Abstract 4983: Intermittent dosing regimens of naproxen and aspirin inhibit azoxymethane-induced rat colon adenoma progression to adenocarcinoma and carcinoma invasion. Cancer Research. 78(13_Supplement). 4983–4983. 3 indexed citations
3.
Janakiram, Naveena B., Altaf Mohammed, Jagan M.R. Patlolla, et al.. (2017). Abstract 5260: NGS Transcriptome analysis of colon adenocarcinomas treated with individual and combination of aspirin and omeprazole. Cancer Research. 77(13_Supplement). 5260–5260. 1 indexed citations
4.
Rao, Chinthalapally V., Yuting Zhang, Laura Biddick, et al.. (2016). Systemic Chromosome Instability Resulted in Colonic Transcriptomic Changes in Metabolic, Proliferation, and Stem Cell Regulators in Sgo1 −/+ Mice. Cancer Research. 76(3). 630–642. 19 indexed citations
5.
Rao, Chinthalapally V., Naveena B. Janakiram, Venkateshwar Madka, et al.. (2016). Small-Molecule Inhibition of GCNT3 Disrupts Mucin Biosynthesis and Malignant Cellular Behaviors in Pancreatic Cancer. Cancer Research. 76(7). 1965–1974. 41 indexed citations
6.
Janakiram, Naveena B., Altaf Mohammed, Yuting Zhang, et al.. (2016). Potentiating NK cell activity by combination of Rosuvastatin and Difluoromethylornithine for effective chemopreventive efficacy against Colon Cancer. Scientific Reports. 6(1). 37046–37046. 23 indexed citations
7.
Mohammed, Altaf, Naveena B. Janakiram, Venkateshwar Madka, et al.. (2016). Abstract 2621: Disruption of mucin synthesis by targeting GCNT3 inhibits pancreatic cancer progression. Cancer Research. 76(14_Supplement). 2621–2621. 1 indexed citations
8.
Madka, Venkateshwar, Altaf Mohammed, Qian Li, et al.. (2015). Targeting mTOR and p53 Signaling Inhibits Muscle Invasive Bladder Cancer In Vivo. Cancer Prevention Research. 9(1). 53–62. 13 indexed citations
9.
Patlolla, Jagan M.R., Levy Kopelovich, Qian Li, et al.. (2015). Early and delayed intervention with Rapamycin prevents NNK-induced lung adenocarcinoma in A/J mice. Oncology Reports. 34(6). 2925–2934. 11 indexed citations
10.
Rao, Chinthalapally V., Yuting Zhang, Laura Biddick, et al.. (2015). Antagonizing pathways leading to differential dynamics in colon carcinogenesis in Shugoshin1 (Sgo1)-haploinsufficient chromosome instability model. Molecular Carcinogenesis. 55(5). 600–610. 8 indexed citations
11.
Mohammed, Altaf, Jagan M.R. Patlolla, Yuting Zhang, et al.. (2015). Abstract 2820: Omeprazole alone, or in combination with Aspirin inhibits azoxymethane-induced colon adenoma progression to adenocarcinoma and carcinoma invasion in F344 rat model. Cancer Research. 75(15_Supplement). 2820–2820. 2 indexed citations
12.
Mohammed, Altaf, Naveena B. Janakiram, Venkateshwar Madka, et al.. (2014). Eflornithine (DFMO) Prevents Progression of Pancreatic Cancer by Modulating Ornithine Decarboxylase Signaling. Cancer Prevention Research. 7(12). 1198–1209. 55 indexed citations
13.
Janakiram, Naveena B., Altaf Mohammed, Misty Brewer, et al.. (2014). Raloxifene and Antiestrogenic Gonadorelin Inhibits Intestinal Tumorigenesis by Modulating Immune Cells and Decreasing Stem-like Cells. Cancer Prevention Research. 7(3). 300–309. 10 indexed citations
14.
Janakiram, Naveena B., Altaf Mohammed, Misty Brewer, et al.. (2014). Adoptive transfer of regulatory T cells promotes intestinal tumorigenesis and is associated with decreased NK cells and IL‐22 binding protein. Molecular Carcinogenesis. 54(10). 986–998. 12 indexed citations
15.
Mohammed, Altaf, Naveena B. Janakiram, Laura Biddick, et al.. (2014). Abstract 2969: Combinational Targeting of EGFR and ODC pathways by Gefitinib and DFMO lead to complete blockade of PanIN progression to pancreatic ductal adenocarcinoma. Cancer Research. 74(19_Supplement). 2969–2969. 1 indexed citations
16.
Madka, Venkateshwar, Altaf Mohammed, Qian Li, et al.. (2014). Chemoprevention of Urothelial Cell Carcinoma Growth and Invasion by the Dual COX–LOX Inhibitor Licofelone in UPII-SV40T Transgenic Mice. Cancer Prevention Research. 7(7). 708–716. 18 indexed citations
17.
Mohammed, Altaf, Qian Li, Misty Brewer, et al.. (2013). Chemopreventive Effects of an HDAC2-Selective Inhibitor on Rat Colon Carcinogenesis and APCmin/+ Mouse Intestinal Tumorigenesis. Journal of Pharmacology and Experimental Therapeutics. 348(1). 59–68. 11 indexed citations
18.
Patlolla, Jagan M.R., Qian Li, Laura Biddick, et al.. (2013). β-Escin Inhibits NNK-Induced Lung Adenocarcinoma and ALDH1A1 and RhoA/Rock Expression in A/J Mice and Growth of H460 Human Lung Cancer Cells. Cancer Prevention Research. 6(10). 1140–1149. 27 indexed citations
19.
Janakiram, Naveena B., Altaf Mohammed, Yuting Zhang, et al.. (2013). Abstract 186: Clinically relevant low dose combination of rosuvastatin and difluoromethylornithine provides effective chemopreventive efficacy against AOM-induced colon cancers in F344 rats .. Cancer Research. 73(8_Supplement). 186–186. 2 indexed citations
20.
Patlolla, Jagan M.R., Levy Kopelovich, Qian Li, et al.. (2012). Abstract B111: Early and Delayed Rapamycin prevents NNK-induced lung adenocarcinoma in A/J mice. Cancer Prevention Research. 5(11_Supplement). B111–B111. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026